Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2003 | 1 |
2004 | 1 |
2005 | 1 |
2006 | 1 |
2007 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Pros and cons of treating murine myasthenia gravis with anti-C1q antibody.
J Neuroimmunol. 2007 Jan;182(1-2):167-76. doi: 10.1016/j.jneuroim.2006.10.014. Epub 2006 Nov 29.
J Neuroimmunol. 2007.
PMID: 17137637
Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis.
Tüzün E, Scott BG, Goluszko E, Higgs S, Christadoss P.
Tüzün E, et al.
J Immunol. 2003 Oct 1;171(7):3847-54. doi: 10.4049/jimmunol.171.7.3847.
J Immunol. 2003.
PMID: 14500686
Item in Clipboard
IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1.
Yang H, Tüzün E, Alagappan D, Yu X, Scott BG, Ischenko A, Christadoss P.
Yang H, et al.
J Immunol. 2005 Aug 1;175(3):2018-25. doi: 10.4049/jimmunol.175.3.2018.
J Immunol. 2005.
PMID: 16034147
Item in Clipboard
ICOS is essential for the development of experimental autoimmune myasthenia gravis.
Scott BG, Yang H, Tüzün E, Dong C, Flavell RA, Christadoss P.
Scott BG, et al.
J Neuroimmunol. 2004 Aug;153(1-2):16-25. doi: 10.1016/j.jneuroim.2004.04.019.
J Neuroimmunol. 2004.
PMID: 15265659
Item in Clipboard
Cite
Cite